These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 18471546)

  • 21. Improved diagnostic accuracy of blood tests for severe fibrosis and cirrhosis in chronic hepatitis C.
    Boursier J; Bacq Y; Halfon P; Leroy V; de Ledinghen V; de Muret A; Bourlière M; Sturm N; Foucher J; Oberti F; Rousselet MC; Calès P
    Eur J Gastroenterol Hepatol; 2009 Jan; 21(1):28-38. PubMed ID: 19060630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New diagnostic method for liver fibrosis and cirrhosis.
    Han KH; Yoon KT
    Intervirology; 2008; 51 Suppl 1():11-6. PubMed ID: 18544943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Role of liver biopsy in the assessment of hepatic fibrosis--its utility and limitations].
    Jin SY
    Korean J Hepatol; 2007 Jun; 13(2):138-45. PubMed ID: 17585187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing liver fibrosis.
    Castera L
    Expert Rev Gastroenterol Hepatol; 2008 Aug; 2(4):541-52. PubMed ID: 19072402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-invasive markers of hepatic fibrosis in patients co-infected with HCV and HIV: comparison of the APRI and FIB-4 index.
    Trang T; Petersen JR; Snyder N
    Clin Chim Acta; 2008 Nov; 397(1-2):51-4. PubMed ID: 18692034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Liver fibrosis: pathophysiology, diagnosis and treatment].
    Pár A; Pár G
    Orv Hetil; 2005 Jan; 146(1):3-13. PubMed ID: 15715367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation and comparison of simple noninvasive indexes for predicting liver fibrosis in HIV-HCV-coinfected patients: ANRS CO3 Aquitaine cohort.
    Loko MA; Castera L; Dabis F; Le Bail B; Winnock M; Coureau G; Bioulac-Sage P; de Ledinghen V; Neau D;
    Am J Gastroenterol; 2008 Aug; 103(8):1973-80. PubMed ID: 18796094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Technology Insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography.
    Pinzani M; Vizzutti F; Arena U; Marra F
    Nat Clin Pract Gastroenterol Hepatol; 2008 Feb; 5(2):95-106. PubMed ID: 18253138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis and therapy of nonalcoholic steatohepatitis.
    Torres DM; Harrison SA
    Gastroenterology; 2008 May; 134(6):1682-98. PubMed ID: 18471547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of hepatitis C: non-invasive fibrosis markers and/or liver biopsy.
    Bedossa P
    Liver Int; 2009 Jan; 29 Suppl 1():19-22. PubMed ID: 19207962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noninvasive tests for liver fibrosis.
    Mukherjee S; Sorrell MF
    Semin Liver Dis; 2006 Nov; 26(4):337-47. PubMed ID: 17051448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is there any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis?
    Vardar R; Vardar E; Demiri S; Sayhan SE; Bayol U; Yildiz C; Postaci H
    Hepatogastroenterology; 2009; 56(94-95):1459-65. PubMed ID: 19950810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Serologic diagnosis of liver fibrosis].
    Sauerbruch T
    Dtsch Med Wochenschr; 1999 Oct; 124(41):1191. PubMed ID: 10572514
    [No Abstract]   [Full Text] [Related]  

  • 34. Non invasive assessment of liver fibrosis.
    Yeshua H; Oren R
    Ann Transplant; 2008; 13(2):5-11. PubMed ID: 18566553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
    Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ
    Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Reversibility of advanced liver fibrosis--therapeutic possibility and biochemical monitoring of the disease].
    Lebensztejn DM
    Przegl Epidemiol; 2005; 59(2):535-40. PubMed ID: 16190564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Assessment of hepatic fibrosis: what is the role of non-invasive markers in 2003?].
    Mallat A; Dhumeaux D
    Gastroenterol Clin Biol; 2003 Apr; 27(4):367-70. PubMed ID: 12759674
    [No Abstract]   [Full Text] [Related]  

  • 38. Screening for liver fibrosis by using a noninvasive biomarker in patients with diabetes.
    Jacqueminet S; Lebray P; Morra R; Munteanu M; Devers L; Messous D; Bernard M; Hartemann-Heurtier A; Imbert-Bismut F; Ratziu V; Grimaldi A; Poynard T
    Clin Gastroenterol Hepatol; 2008 Jul; 6(7):828-31. PubMed ID: 18524692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Noninvasive assessment of liver fibrosis: serum markers, imaging, and other modalities.
    Guha IN; Rosenberg WM
    Clin Liver Dis; 2008 Nov; 12(4):883-900, x. PubMed ID: 18984472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review of diagnostic techniques of hepatic fibrosis.
    Hassan S; Syed S; Kehar SI
    J Pak Med Assoc; 2014 Aug; 64(8):941-5. PubMed ID: 25252523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.